- Home
- SLRN vs OPFI Comparison
SLRN vs OPFI Comparison
Compare SLRN & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- OPFI
- Stock Information
- Founded
- SLRN 2020
- OPFI 2009
- Country
- SLRN United States
- OPFI United States
- Employees
- SLRN N/A
- OPFI N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- OPFI Finance: Consumer Services
- Sector
- SLRN Health Care
- OPFI Finance
- Exchange
- SLRN Nasdaq
- OPFI Nasdaq
- Market Cap
- SLRN 224.6M
- OPFI 205.2M
- IPO Year
- SLRN 2023
- OPFI N/A
- Fundamental
- Price
- SLRN $2.41
- OPFI $11.54
- Analyst Decision
- SLRN Hold
- OPFI Buy
- Analyst Count
- SLRN 5
- OPFI 2
- Target Price
- SLRN $9.60
- OPFI $11.75
- AVG Volume (30 Days)
- SLRN 731.5K
- OPFI 800.9K
- Earning Date
- SLRN 05-16-2025
- OPFI 05-07-2025
- Dividend Yield
- SLRN N/A
- OPFI 2.15%
- EPS Growth
- SLRN N/A
- OPFI N/A
- EPS
- SLRN N/A
- OPFI 0.36
- Revenue
- SLRN N/A
- OPFI $276,770,000.00
- Revenue This Year
- SLRN $267.11
- OPFI $112.50
- Revenue Next Year
- SLRN N/A
- OPFI $7.84
- P/E Ratio
- SLRN N/A
- OPFI $32.25
- Revenue Growth
- SLRN N/A
- OPFI 22.23
- 52 Week Low
- SLRN $1.85
- OPFI $2.82
- 52 Week High
- SLRN $7.25
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- SLRN 53.86
- OPFI 72.32
- Support Level
- SLRN $2.34
- OPFI $9.43
- Resistance Level
- SLRN $2.64
- OPFI $12.30
- Average True Range (ATR)
- SLRN 0.16
- OPFI 0.49
- MACD
- SLRN 0.02
- OPFI 0.33
- Stochastic Oscillator
- SLRN 67.83
- OPFI 86.43
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.